• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
  

PubMed=7798295; DOI=10.1007/BF01194268
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Kalle Alanen, Taina Lakkala, Reidar Grenman;
Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.
J. Cancer Res. Clin. Oncol. 120:712-716(1994)

PubMed=8123477; DOI=10.1038/bjc.1994.87; PMCID=PMC1968845
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Reidar Grenman;
Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
Br. J. Cancer 69:482-486(1994)

PubMed=7821848; DOI=10.1006/gyno.1995.1009
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Misa Jaakkola, Taina Lakkala, Antti Sajantila, Pekka Klemi, Reidar Grenman;
Characterization and radiosensitivity of UT-EC-2A and UT-EC-2B, two new highly radiosensitive endometrial cancer cell lines derived from a primary and metastatic tumor of the same patient.
Gynecol. Oncol. 56:53-62(1995)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Virpi Rantanen, Seija E. Grenman, Kaisa Kurvinen, Sakari H. Hietanen, Misa Raitanen, Stina M. Syrjanen;
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)